Dine Brands rejected a $39-per-share, nonbinding offer from Arkhouse and Cobblers Cove and adopted a poison pill, calling the bid inadequate. Q3 earnings land Wednesday.
We use cookies for analytics and site preferences. Choose what to allow. Cookie policy